The TGF-β response to Leishmania chagasi in the absence of IL-12

European Journal of Immunology

Volumn 32, Issue 12, 2002, Pages 3556-3565

  Wilson, Mary E ^a,b,c   Recker, Thomas J ^a,b   Rodriguez, Nilda E ^c   Young, Betty M ^b   Burnell, Kindra K ^a,b   Streit, Judy A ^b   Kline, Joel N ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Cytokine; Dendritic cell; IL 12; Parasitic protozoan infection; Vaccination

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; PROTEIN P40; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE EXACERBATION; IMMUNE RESPONSE; INFECTION SENSITIVITY; KNOCKOUT MOUSE; LEISHMANIA CHAGASI; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL;

EID: 0036918765     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200212)32:12<3556::AID-IMMU3556>3.0.CO;2-Q     Document Type: Article

References (54)

1. Gantt, K. R., Goldman, T. L., Miller, M. A., McCormick, M. L., Jeronimo, S. M. B., Nascimento, E. T., Britigan, B. E. and Wilson, M. E., Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J. Immunol. 2001. 167: 893-901.
2. Murray, H. W. and Nathan, C. F., Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 1999. 189: 741-746.
3. Reiner, S. L. and Locksley, R. M., The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 1995. 13: 151-177.
4. Jones, D. E., Elloso, M. M. and Scott, P., Host susceptibility factors to cutaneous leishmaniasis. Frontiers Biosci. 1998. 3: 1171-1180.
5. Kaye, P. M., Curry, A. J. and Blackwell, J. M., Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 1991. 146: 2763-2770.
6. Wilson, M. E., Sandor, M., Blum, A. M., Young, B. M., Metwali, A., Elliott, D., Lynch, R. G. and Weinstock, J. V., Local suppression of IFN-γ in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J. Immunol. 1996. 156: 2231-2239.
7. Wilson, M. E., Young, B. M., Davidson, B. L., Mente, K. A. and McGowan, S. E., The importance of transforming growth factor-β in murine visceral leishmaniasis. J. Immunol. 1998. 161: 6148-6155.
8. Trinchieri, G. and Gerosa, F., Immunoregulation by interleukin-12. J. Leukoc. Biol. 1996. 59: 505-511.
9. Guler, M. L., Gorham, J. D., Hsieh, C.-S., Mackey, A. J., Steen, R. G., Dietrich, W. F. and Murphy, K. M., Genetic susceptibility to Leishmania: IL-12 responsivenenss in Th1 cell development. Science 1996. 271: 984-987.
10. Scharton-Kersten, T., Afonso, L. C. C., Wysocka, M., Trinchieri, G. and Scott, P., IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 1995. 154: 5320-5330.
11. Heinzel, F. P., Rerko, R. M., Ahmed, F. and Pearlman, E., Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 1995. 155: 730-739.
12. Jones, D., Elloso, M. M., Showe, L., Willimans, D., Trinchieri, G. and Scott, P., Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major. Infect. Immun. 1998. 66: 3818-3824.
13. Jones, D. E., Buxbaum, L. U. and Scott, P., IL-4 independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 2000. 165: 364-372.
14. Letterio, J. J. and Roberts, A. B., Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 1998. 16: 137-161.
15. Ludviksson, B. R., Seegers, D., Resnick, A. S. and Strober, W., The effect of TGF-β1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells. Eur. J. Immunol. 2000. 30: 2101-2111.
16. Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C.-Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A. and Gately, M. K., IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 1996. 4: 471-481.
17. Mencacci, A., Cenci, E., Del Sero, G., d'Ostiani, C. F., Mosci, P., Trinchieri, G., Adorini, L. and Romani, L., IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J. Immunol. 1998. 161: 6228-6237.
18. Mattner, F., Magram, J., Ferrante, J., Launois, P., Padova, K. D., Behin, R., Gately, M. K., Louis, J. A. and Alber, G., Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 response. Eur. J. Immunol. 1996. 26: 1553-1559.
19. Mattner, F., Padova, K. D. and Alber, G., Interleukin-12 is indispensable for protective immunity against Leishmania major. Infect. Immun. 1997. 65: 4378-4383.
20. Park, A. Y., Hondowicz, B. D., Kopf, M. and Scott, P., The role of IL-12 in maintaining resistance to Leishmania major. J. Immunol. 2002. 168: 5771-5777.
21. Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Akita, K., Namba, M., Tanabe, F., Konishi, K., Fukuda, S. and Kurimoto, M., Cloning of a new cytokine that induced IFN-γ production by T cells. Nature 1995. 378: 88-91.
22. Banchereau, J., Briere, F., Caux, C., Davoust, J., Legecque, S., Liu, Y.-J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767-811.
23. Park, A. Y., Hondowicz, B. D. and Scott, P., IL-12 is required to maintain a Th1 response during Leishmania major infection. J. Immunol. 2000. 165: 896-902.
24. Yap, G., Pesin, M. and Sher, A., IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 2000. 165: 628-631.
25. Streit, J. A., Recker, T. J., Filho, F. G., Beverley, S. M. and Wilson, M. E., Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms. J. Immunol. 2001. 166: 1921-1929.
26. + T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997. 389: 737-742.
27. Strober, W., Kelsall, B., Fuss, I., Marth, T., Ludviksson, B., Ehrhardt, R. and Neurath, M., Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol. Today 1997. 18: 61-64.
28. Gomes, N. A., Gattass, C. R., Barreto-de-Souza, V., Wilson, M. E. and DosReis, G. A., Transforming growth factor beta regulates CTLA-4 suppression of cellular immunity in murine Kala-Azar. J. Immunol. 2000. 164: 2001-2008.
29. Gorham, J. D., Guler, M. L., Fenoglio, D., Gubler, U. and Murphy, K. M., Low dose TGF-β attenuates IL-12 responsiveness in murine Th cells. J. Immunol. 1998. 161: 1664-1670.
30. Barral-Netto, M., Barral, A., Brownell, C. E., Skeiky, Y. A. W., Ellingsworth, L. R., Twardzik, D. R. and Reed, S. G., Transforming growth factor-β in leishmanial infection: A parasite escape mechanism. Science 1992. 257: 545-548.
31. Rodrigues, , V., Jr., Da Silva, J. S. and Campos-Neto, A., Transforming growth factor β and immunosuppression in experimental visceral leishmaniasis. Infect. Immun. 1998. 66: 1233-1236.
32. Melby, P. C., Chandrashekar, R., Zhao, W. and Coe, J. E., The Hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of prominent Th1-like cytokine response. J. Immunol. 2001. 166: 1912-1920.
33. Barral, A., Barral-Netto, M., Yong, E. C., Brownell, C. E., Twardzik, D. R. and Reed, S. G., Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. USA 1993. 90: 3442-3446.
34. Li, J., Hunter, C. A. and Farrell, J. P., Anti-TGF-β treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J. Immunol. 1999. 162: 974-979.
35. Gorelik, L., Constant, S. and Flavell, R. A., Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 2002. 195: 1499-1505.
36. Diefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T., MacMicking, J., Rollinghoff, M., Gresser, I. and Bogdan, C., Type 1 interferon (IFN αβ) and type 2 nitric oxide synthase regulated the innate immune response to a protozoan parasite. Immunity 1998. 8: 77-87.
37. Schindler, H., Diefenbach, A., Rollinghoff, M. and Bogdan, C., IFN-γ inhibits the production of latent transforming growth factor-β1 by mouse inflammatory macrophages. Eur. J. Immunol. 1998. 28: 1181-1188.
38. Marth, T., Strober, W., Seder, R. A. and Kelsall, B. L., Regulation of transforming growth factor-β production by interleukin-12. Eur. J. Immunol. 1997. 27: 1213-1220.
39. + T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production. J. Immunol. 1998. 160: 5719-5728.
40. Belkaid, Y., Mendez, S., Lira, R., Kadambi, N., Milon, G. and Sacks, D., A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formationand immunity. J. Immunol. 2000. 165: 969-977.
41. Lira, R., Doherty, M., Modi, G. and Sacks, D. L., Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major. Infect. Immun. 2000. 68: 5176-5182.
42. Murray, H. W., Montelibano, C., Peterson, R. and Sypek, J. P., Interleukin-12 regulates the response to chemotherapy in experimental visceral leishmaniasis. J. Infect. Dis. 2001. 182: 1497-1502.
43. Sutterwala, F. S., Noel, G. J., Clynes, R. and Mosser, D. M., Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 1997. 185: 1977-1985.
44. von Stebut, E., Belkaid, Y., Jakob, T, Sacks, D. L. and Udey, M. C., Uptake of Leishmania major amastigotes results in activation and Interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 1998. 188: 1547-1552.
45. Schijns, V. E. C. J., Haagmans, B. L., Wierda, C. M. H., Kruithof, B., Heijnen, I. A. F. M., Alber, G. and Horzinek, M. C., Mice lacking IL-12 develop polarized Th1 cells during viral infection. J. Immunol. 1998. 160: 3958-3964.
46. Stobie, L., Gurunathan, S., Prussin, C., Sacks, D. L., Glaichenhaus, N., Wu, C.-Y. and Seder, R. A., The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory-effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc. Natl. Acad. Sci. USA 2000. 97: 8427-8432.
47. Chakraborty, A., Li, L., Chakraborty, N. G. and Mukherji, B., Stimulatory and inhibitory maturation of human macrophage-derived dendritic cells. Pathobiology 1999. 67: 282-286.
48. Bastos, K. R. B., Alvarez, J. M., Marinho, C. R. F., Rizzo, L. V. and Lima, M. R. D., Macrophages from IL-12p40-deficient mice have a biase toward the M2 activation profile. J. Leukoc. Biol. 2002. 71: 271-278.
49. Fukaura, H., Kent, S. C., Pietrusewicz, M. J., Khoury, S. J., Weiner, H. L. and Hafler, D. A., Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 1996. 98: 70-77.
50. Omer, F. M., Kurtzhals, J. A. L and Riley, E. M., Maintaining the immunological balance in parastic infections: A role for TGF-β? Parasitol. Today 2000. 16: 18-23.
51. Ming, M., Ewen, M. E. and Pereira, M. E. A., Trypanosome invasion of mammalian cells requires activation of the TGFβ signaling pathway. Cell 1995. 82: 287-296.
52. Kline, J. N., Krieg, A. M., Waldschmidt, T., Ballas, Z. K., Jain, V. and Businga, T. R., CpG oligodeoxynucleotides do not require Th1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J. Allergy Clin. Immunol. 1999, 104: 1258-1264.
53. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte-macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.
54. Ashley, D. M., Faiola, B., Nair, S., Hale, L. P., Bigner, D. D. and Gilboa, E., Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J. Exp. Med. 1997. 186: 1177-1182.